TaiDoc - Public Comps and Valuation Multiples

TaiDoc Overview

About TaiDoc

TaiDoc Technology Corp is in the business of manufacturing and marketing electronic components and medical devices. It focuses on providing complete solutions covering Home care diagnostics, Professional instruments, and Telehealth systems. Its products and services include a Blood glucose monitoring system, Multiple parameters monitoring system, Irregular heartbeat detection, Vital sign monitor, Nebulizer, and others. The firm's manufacturing facilities are in Taipei and Taoyuan. It has three segments Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from Americas, Middle East, and others.

Founded

1998

HQ

Employees

1.0K+

Website

taidoc.com

Sectors

Medical Devices
Health Data & Analytics
HealthTech
DeepTech

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$258M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

TaiDoc Financials

TaiDoc has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, TaiDoc achieved revenue of $140M and an EBITDA of $49.9M.

TaiDoc expects next 12-month revenue of XXX and NTM EBITDA of XXX

See TaiDoc valuation multiples based on analyst estimates

TaiDoc P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$145M	$140M	XXX	XXX	XXX
Gross Profit	$170M	$62.6M	XXX	XXX	XXX
Gross Margin	117%	45%	XXX	XXX	XXX
EBITDA	$47.5M	$49.9M	XXX	XXX	XXX
EBITDA Margin	33%	36%	XXX	XXX	XXX
Net Profit	$102M	$30.7M	XXX	XXX	XXX
Net Margin	70%	22%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

TaiDoc Stock Performance

As of April 15, 2025, TaiDoc's stock price is TWD 130 (or $4).

TaiDoc has current market cap of TWD 12.4B (or $376M), and EV of TWD 8.6B (or $258M).

See TaiDoc trading valuation data

TaiDoc Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$258M	$376M	XXX	XXX	XXX	XXX	$0.33

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

TaiDoc Valuation Multiples

As of April 15, 2025, TaiDoc has market cap of $376M and EV of $258M.

TaiDoc's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate TaiDoc's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for TaiDoc and 10K+ public comps

TaiDoc Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$258M	XXX	XXX	XXX
EV/Revenue	1.8x	XXX	XXX	XXX
EV/EBITDA	5.2x	XXX	XXX	XXX
P/E	10.7x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	-15.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get TaiDoc Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

TaiDoc Valuation Multiples

TaiDoc's NTM/LTM revenue growth is n/a

TaiDoc's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $37K for the same period.

Over next 12 months, TaiDoc's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate TaiDoc's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for TaiDoc and other 10K+ public comps

TaiDoc Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	-3%	XXX	XXX	XXX	XXX
EBITDA Margin	36%	XXX	XXX	XXX	XXX
EBITDA Growth	5%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	$0.1M	XXX	XXX	XXX	XXX
Opex per Employee	$37K	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	11%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	8%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	8%	XXX	XXX	XXX	XXX
Opex to Revenue	27%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry